Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Fasting as a Primary Means for Improving Quality of Life for Acute and Chronic Pancreatitis

NCT04760847 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT04760847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04760847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Fasting as a Primary Means for Improving Quality of Life for Acute and Chronic Pancreatitis
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2027
Completion date
March 31, 2030
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute recurrent pancreatitis, pancreas disease, pancreatitis, pancreatitis, acute, pancreatitis, chronic